Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib

NCT01070706 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel,Gemcitabine,Sunitinib

Sponsor

Jungsil Ro

Collaborators

[object Object]
[object Object]